What is a key purpose of the Combat Methamphetamine Epidemic Act of 2005?

The key purpose of the Combat Methamphetamine Epidemic Act of 2005 is to regulate the over-the-counter (OTC) sales of pseudoephedrine, which is a common ingredient found in many cold and allergy medications. The act was implemented in response to the growing concern over the production of methamphetamine, which often utilizes pseudoephedrine as a key precursor chemical.

Under this legislation, retailers are required to keep pseudoephedrine products behind the pharmacy counter or in a locked cabinet, ensuring that they can monitor sales more effectively. Additionally, there are restrictions on the amount that can be purchased by an individual within a certain timeframe, along with identification requirements for purchasers. This regulatory approach aims to curb the illicit use of pseudoephedrine in methamphetamine production while allowing legitimate access for those in need of these medications for treating cold and allergy symptoms.

In contrast, the other options focus on aspects unrelated to the primary intent of this act. Limiting prescription lengths, increasing access to pain medications, and assisting in patient record-keeping are not central to addressing the specific issues tied to methamphetamine production and the use of pseudoephedrine highlighted by the Combat Methamphetamine Epidemic Act.